Results 61 to 70 of about 117 (84)
Salud Pública de México, 2016 Dengue is a major global public health problem which affects Latin America and Mexico. The prevention and control measures focusing on epidemiological surveillance and vector control have been partially effective as well as costly; thus, the development ...
Mauricio Hernández-Ávila +1 more
doaj
State of the Art on Vaccine Development Against Dengue Infection: Scoping Review of the Literature
Infectious Disease ReportsBackground: Dengue virus infection is a significant challenge for global health, with 100 million symptomatic cases, 2.3 million DALYs and 20,000 deaths annually.
Davide Marangoni +6 more
doaj +1 more source
Frontiers in MicrobiologyBackgroundThe evolutionary dynamics of dengue virus type 1 (DENV-1) in non-endemic settings such as southeastern coastal China where outbreaks predominantly stem from imported cases, remains insufficiently defined, particularly in relation to lineage ...
Tianran Zhang +13 more
doaj +1 more source
Dengue Vaccine Development and Deployment into Routine Immunization
VaccinesDengue has emerged as a significant global health threat. Despite decades of research, only two dengue vaccines—CYD-TDV (Dengvaxia) and TAK-003 (Qdenga)—have been licensed to date, with limited implementation.
Annelies Wilder-Smith +2 more
doaj +1 more source
Eficacia y seguridad de las nuevas vacunas contra el dengue
Evidencia. Actualización en la Práctica AmbulatoriaEste artículo es la actualización de un EOP publicado en 2021 sobre la eficacia y la seguridad de las vacunas contra el dengue. En la práctica, la inmunización con la única vacuna aprobada por la Agencia Nacional de Medicamentos, Alimentos y Tecnologia ...
Valeria Vietto +2 more
doaj +1 more source
Unveiling the complexity of vaccine hesitancy: A narrative review focusing on dengue vaccination
Human Vaccines & ImmunotherapeuticsDengue vaccines face significant challenges, including safety concerns, which contribute to vaccine hesitancy. Addressing this complex issue requires targeted strategies to overcome existing barriers.
Rachata Charoenwisedsil +5 more
doaj +1 more source
Current status of the development of dengue vaccines
Vaccine: XDengue fever is caused by the mosquito-borne dengue virus (DENV), which is endemic in more than 100 countries. Annually, there are approximately 390 million dengue cases, with a small subset manifesting into severe illnesses, such as dengue haemorrhagic ...
Michelle Felicia Lee +2 more
doaj +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches: